Gene expression patterns of CRYM and SIGLEC10 in Alzheimer's disease: potential early diagnostic indicators

Area of Science:

• Neuroscience
• Genetics
• Biomarker Discovery

Background:

• Alzheimer's disease (AD) is a progressive neurological disorder leading to dementia.
• Early diagnosis of AD remains a significant challenge in clinical practice.
• Identifying reliable early diagnostic markers for AD is crucial.

Purpose of the Study:

• To investigate differential gene expression of crystallin mu (CRYM) and sialic acid-binding immunoglobulin-like lectin 10 (SIGLEC10) in Alzheimer's disease.
• To evaluate the potential of CRYM and SIGLEC10 as diagnostic biomarkers for AD.

Main Methods:

• Gene expression analysis of CRYM and SIGLEC10 in whole blood samples.
• Comparison between 50 individuals diagnosed with AD and 50 healthy controls.
• Statistical analysis including correlation and receiver operating characteristic (ROC) curve analysis.

Main Results:

• CRYM gene expression was significantly decreased in AD patients compared to controls.
• SIGLEC10 gene expression was significantly elevated in AD patients.
• CRYM and SIGLEC10 transcript levels showed diagnostic potential with AUCs of 0.74 and 0.81, respectively.

Conclusions:

• Altered CRYM and SIGLEC10 expression patterns are potentially linked to AD pathology.
• These genes may serve as valuable biomarkers for the early detection and diagnosis of AD.
• Further validation in larger, diverse cohorts is necessary to confirm these findings and advance diagnostic strategies.